Board meeting scheduled for May 19, 2026 to approve audited financial results for Q4 and FY ending March 31, 2026.
Agenda includes consideration of standalone and consolidated financial statements and potential dividend recommendation for FY 2025-26.
Trading window closure for designated employees from April 1, 2026 until 48 hours after results declaration.